Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
IDH Family Wildtype, Recurrent Anaplastic Astrocytoma or Recurrent Glioblastoma
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This phase II trial studies how well laser interstitial thermal therapy and lomustine work in treating patients with glioblastoma or anaplastic astrocytoma that has come back. Using laser to heat the tumor cells may help to kill them. Drugs used in chemotherapy, such as lomustine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving laser interstitial thermal therapy and lomustine may work better in treating patients with glioblastoma or anaplastic astrocytoma.

Provided treatments

  • Procedure: Laser Interstitial Thermal Therapy
  • Drug: Lomustine
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03022578. The sponsor of the trial is M.D. Anderson Cancer Center and it is looking for 34 volunteers for the current phase.
Official trial title:
Phase II Study of Laser Interstitial Thermal Therapy (LITT) in Recurrent Glioblastoma